NASENI Commits to Healthcare Innovation at Malaria Program

The National Agency for Science and Engineering Infrastructure (NASENI), represented by Executive Vice Chairman and Chief Executive Officer Khalil Suleiman Halilu, reaffirmed its commitment to healthcare innovation at the closing dinner of the Harvard-led Science Defeat Malaria program held in Abuja. This event followed a visit to NASENI's biotechnological facility, which plays a crucial role in advancing disease control and healthcare innovation in Africa.

Halilu emphasized the agency's strategy to reduce Nigeria's dependency on imported diagnostic kits and strengthen local healthcare manufacturing capacity. The facility is designed to produce 600 million diagnostic kits annually, meeting 80 percent of Nigeria's diagnostic test needs and creating opportunities for export to other African countries.

The facility manufactures rapid diagnostic tests and in vitro diagnostic products for various diseases, including malaria, hepatitis B and C, HIV, typhoid, syphilis, COVID-19, pregnancy, and blood glucose monitoring. Halilu expressed appreciation for the recognition of progress made by the Harvard delegation, reinforcing NASENI's commitment to developing innovative solutions to improve lives in Nigeria and establish the country as a healthcare manufacturing hub in Africa.